459 related articles for article (PubMed ID: 28145405)
1. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
[TBL] [Abstract][Full Text] [Related]
2. Evidence that immunization with TP0751, a bipartite Treponema pallidum lipoprotein with an intrinsically disordered region and lipocalin fold, fails to protect in the rabbit model of experimental syphilis.
Luthra A; Montezuma-Rusca JM; La Vake CJ; LeDoyt M; Delgado KN; Davenport TC; Fiel-Gan M; Caimano MJ; Radolf JD; Hawley KL
PLoS Pathog; 2020 Sep; 16(9):e1008871. PubMed ID: 32936831
[TBL] [Abstract][Full Text] [Related]
3. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
[TBL] [Abstract][Full Text] [Related]
4. Immunization with Tp0954, an adhesin of
He Y; Chen D; Fu Y; Huo X; Zhao F; Yao L; Zhou X; Qi P; Yin H; Cao L; Ling H; Zeng T
Front Immunol; 2023; 14():1130593. PubMed ID: 36993963
[TBL] [Abstract][Full Text] [Related]
5. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
Front Immunol; 2021; 12():759474. PubMed ID: 34899710
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin.
Zheng K; Xu M; Xiao Y; Luo H; Xie Y; Yu J; Tan M; Li Y; Zhao F; Zeng T; Wu Y
Emerg Microbes Infect; 2018 Nov; 7(1):177. PubMed ID: 30405111
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
[TBL] [Abstract][Full Text] [Related]
8. Syphilis Vaccine Development: Requirements, Challenges, and Opportunities.
Cameron CE
Sex Transm Dis; 2018 Sep; 45(9S Suppl 1):S17-S19. PubMed ID: 29528992
[TBL] [Abstract][Full Text] [Related]
9. Immunization of rabbits with Spirochaeta aurantia does not induce resistance to Treponema pallidum.
Graves S; Drummond L; Strugnell R
Sex Transm Dis; 1984; 11(1):1-5. PubMed ID: 6369574
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Neuroinvasive Pathogen Host Target, LamR, as an Endothelial Receptor for the Treponema pallidum Adhesin Tp0751.
Lithgow KV; Church B; Gomez A; Tsao E; Houston S; Swayne LA; Cameron CE
mSphere; 2020 Apr; 5(2):. PubMed ID: 32238570
[No Abstract] [Full Text] [Related]
11. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
Tomson FL; Conley PG; Norgard MV; Hagman KE
Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
[TBL] [Abstract][Full Text] [Related]
12. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-TP0136 antibodies on the progression of lesions in an infected rabbit model.
Li QL; Tong ML; Liu LL; Lin LR; Lin Y; Yang TC
Int Immunopharmacol; 2020 Jun; 83():106428. PubMed ID: 32217461
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Protective Ability of the Treponema pallidum subsp.
Haynes AM; Godornes C; Ke W; Giacani L
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182617
[No Abstract] [Full Text] [Related]
16. Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete.
Kao WA; Pětrošová H; Ebady R; Lithgow KV; Rojas P; Zhang Y; Kim YE; Kim YR; Odisho T; Gupta N; Moter A; Cameron CE; Moriarty TJ
Sci Rep; 2017 May; 7(1):1538. PubMed ID: 28484210
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum.
Lukehart SA; Molini B; Gomez A; Godornes C; Hof R; Fernandez MC; Pitner RA; Gray SA; Carter D; Giacani L; Cameron CE
Vaccine; 2022 Dec; 40(52):7676-7692. PubMed ID: 36376214
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Treponema pallidum laminin-binding protein.
Cameron CE
Infect Immun; 2003 May; 71(5):2525-33. PubMed ID: 12704124
[TBL] [Abstract][Full Text] [Related]
19. Progress towards an effective syphilis vaccine: the past, present and future.
Cullen PA; Cameron CE
Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of the Treponema pallidum laminin-binding adhesin Tp0751 in the culturable spirochete Treponema phagedenis.
Cameron CE; Kuroiwa JM; Yamada M; Francescutti T; Chi B; Kuramitsu HK
J Bacteriol; 2008 Apr; 190(7):2565-71. PubMed ID: 18263731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
